• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>WisdomTree Dreyfus Euro

WisdomTree Dreyfus Euro

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. CHMP RECOMMENDS JINARC® (TOLVAPTAN) FOR APPROVAL IN EU : THE FIRST PHARMACEUTICAL TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

    CHMP RECOMMENDS JINARCĀ® (TOLVAPTAN) FOR APPROVAL IN EU : THE FIRST PHARMACEUTICAL TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

  2. Fitch Releases Report on Lubbock-Cooper Independent School District, TX

    Fitch Releases Report on Lubbock-Cooper Independent School District, TX

  3. Fitch Affirms Kellogg's IDRs at 'BBB+/F2'; Outlook Revised to Negative

    Fitch Affirms Kellogg's IDRs at 'BBB+/F2'; Outlook Revised to Negative

  4. Fitch Publishes Rating Navigators for U.S. Business Service - DAP Companies

    Fitch Publishes Rating Navigators for U.S. Business Service - DAP Companies

  5. Fitch Places El Paso County Hospital District, TX on Rating Watch Negative

    Fitch Places El Paso County Hospital District, TX on Rating Watch Negative

  6. UPDATE: IMF bent its rules to hobble Greece with unsustainable debt

    UPDATE: IMF bent its rules to hobble Greece with unsustainable debt

  7. Fitch: Colombian Electricity Sector - Strong Reserve Margin to Continue

    Fitch: Colombian Electricity Sector - Strong Reserve Margin to Continue

  8. Broadcom Innovation Powers KT 4G LTE Small Cell Deployments

    Broadcom Innovation Powers KT 4G LTE Small Cell Deployments

  9. Fitch Affirms North Tarrant Express Mobility Partners, LLC Revs at 'BBB-'; Outlook Stable

    Fitch Affirms North Tarrant Express Mobility Partners, LLC Revs at 'BBB-'; Outlook Stable

  10. Fitch Rates CSMC Trust 2015-1

    Fitch Rates CSMC Trust 2015-1

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.